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The Lived Experience of Refractory Breathlessness  
Abstract  
 
Introduction: Refractory breathlessness is breathlessness at rest or on minimal exertion that 
persists chronically even with optimal treatment of the underlying cause. Despite its burden 
and prevalence globally, symptoms remain under-treated and under-researched and those 
affected struggle daily with the condition.  
Aim: The aim of the study was to gain a greater understanding of the lived experience of 
refractory breathlessness. Also, it was anticipated that a deeper insight into its impacts on 
daily activities would allow more effective occupational therapy interventions to be 
developed.  
Method: A qualitative phenomenological approach using NVivo software, with one-on-one, 
semi-structured interviews and themes established through thematic analysis. The study 
recruited consecutive patients until thematic saturation was reached. Participants were 
recruited from a Sydney-based outpatient Breathlessness Clinic at a palliative care hospital.  
Results: 6 participants were interviewed and 4 main themes identified. 1) Living on the Edge, 
referring to the extreme feeling of breathlessness experienced by patients; 2) Social Needs, 
describing the significance of social support; 3) Reduced to the Basics, referring to the effect 
breathlessness has on basic daily tasks, and 4) Sources of Security, which describes the 
measures participants take to protect themselves from their own breathlessness. For each of 
the four themes, three to five subthemes were also identified through the analysis.  
Conclusion: Of the 4 themes identified in this study, number 3 and 4 may represent the best 
targets for occupational therapy interventions. Patients noted the importance of functional 
participation for improved engagement and quality of life. There is scope to develop specific 
interventions for self management and equipment prescription given lack of published 
literature in this area.  
MeSH terms: dyspnea, occupational therapy, chronic obstructive pulmonary disease, 
activities of daily living, palliative care. 
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Introduction 
 
Breathlessness is a commonly experienced symptom for people with a variety of malignant 
and non-malignant diseases (Chin & Booth, 2016). It is defined as: “a subjective experience 
of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity. 
The experience derives from multiple physiological, psychological, social, and environmental 
factors, and may induce secondary physiological and behavioural responses” (American 
Thoracic Society, 1999, p. 322). This description captures the complex nature of 
breathlessness. It has also been described as the uncomfortable awareness of the need to 
breathe but the loss of the ability to breathe with ease or confidence (Booth, Burkin, Moffat, 
& Spathis, 2014).  
Breathlessness is a common symptom for individuals living with advanced disease. However, 
the disease trajectory can vary greatly according to the underlying condition (Booth, Moosavi, 
& Higginson, 2008).  While breathlessness is most obviously associated with exertion, in its 
severe forms and at the end of life it may continue even when the individual is at rest (Booth 
et al., 2008). 
Dyspnoea is associated with cardio-respiratory, malignant and non-malignant disease as well 
as some conditions such as renal and neurological illnesses (Booth et al., 2014). The most 
debilitating form of breathlessness is refractory breathlessness (refractory dyspnoea), defined 
as “breathlessness at rest or on minimal exertion that will persist chronically despite optimal 
treatment of the underlying cause(s)” (Currow, Abernethy, & Ko, 2014, p. 393).  
 
Conditions commonly associated with refractory breathlessness include chronic obstructive 
pulmonary disease (COPD), cancer, bronchiectasis and heart failure. Patients experiencing 
refractory breathlessness are often markedly debilitated by their medical condition. Some are 
in a stage of palliative care. It is important to note that a number of studies analysed in this 
literature review focus on one single condition such as COPD, heart failure or cancer (Booth 
et al., 2014). 
 
Despite the severity and chronic nature of refractory breathlessness, as well as the number of 
people affected, it remains under-researched (Currow et al., 2016; Currow et al., 2010; 
Dorman et al., 2009; Maddocks, Reilly, Jolley, & Higginson, 2014).  
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Search strategy 
 
A comprehensive search strategy was conducted in order to identify the literature most 
relevant to this study (see Appendix). The electronic databases CINAHL, Medline, OT Seeker, 
and Web of Science were searched for this review using the following key search terms:  
Dyspnoea, (short* adj3 breath), breathless*, (difficult* adj2 breath*), chronic disease, 
(chronic* or refractor* or persistent*), severe, ((end or late) adj2 stage*), self report, patient* 
adj2 experience*), exp “activity of daily living”. 
English language was selected but publication dates remained undefined to include all 
potentially relevant literature. Over 750 articles were found. These articles were then title and 
abstract screened. The 70 remaining after abstract screening were reviewed in full and sorted 
relevant to this study. In addition, an extensive handpicking of articles and text books was 
conducted.  
 
Theoretical framework - The International Classification of Functioning, Disability and 
Health (ICF) 
 
 
 
Image: (World Health Organisation, 2002). 
The ICF is the World Health Organisation’s framework for health and disability (World 
Health Organisation, 2002). It is a bio-psychosocial model of human functioning and 
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disability that focuses on the functional and disability level of an individual. Functional 
meaning all body functions, activities and participation, and disability indicating impairment, 
activity limitations and restrictions in participation (World Health Organisation, 2002).  
This model has a medical frame focusing on the health condition of the patient, but considers 
that condition in all dimensions such as impairment at the body and body part level, activity 
limitations, and societal level of restrictions in participation, as well as environmental and 
personal factors (World Health Organisation, 2002).  
The framework is used alongside a medical diagnosis, meeting the reality of the varied needs 
of individuals with refractory breathlessness while also considering their personal 
experiences. A diagnosis alone cannot predict the level of care the patient will need (World 
Health Organisation, 2002). This model can help to recognise barriers and influences in the 
medical picture. An effective treatment plan can highlight functional capacities and 
intervention possibilities. This is particularly relevant from an occupational therapy 
perspective where the potential for meaningful intervention is great (Morgan & White, 2012).  
The ICF is structured around the following broad components. 
Three levels of human functioning: 
• Body functions and structure (Impairments – for example, physiological functions of 
the body systems and anatomical parts of the body, such as lungs); 
• Activities (Limitations, including difficulties an individual may have in carrying out 
their meaningful activities); 
• Participation (Restrictions – problems an individual may experience involving life 
situations ranging from daily self-care to work, community activities, family or social 
responsibilities, access to medical support). 
Contextual factors:  
• Environmental factors (living conditions, social, physical, climate, occupational 
situation) 
• Personal factors (age, co-morbidities, personality, levels of care and support, home 
safety, financial means). 
The general principles that underpin the ICF as a health classification model include:  
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- Universality – this model can be used for all people regardless of health condition. Not 
labelling someone with a disability separately. 
- Parity – Health conditions should not be separated by mental or physical 
classifications of function and disability. 
- Neutrality – neutral stance when expressing positive and negative aspects of 
functioning and disability. 
- Environmental factors – influencing at least somewhat both outcome and potential.  
Individuals suffering with refractory breathlessness share an exceptionally severe symptom 
that limits their participation in activities and daily life, though perhaps to varying degrees 
due to their disease aetiology and their stage of illness (Booth et al., 2014). This model 
therefore creates an excellent framework to compare and analyse results of studies undertaken 
in this area. An example of the ICF applied to individuals with refractory breathlessness is 
located in the appendix. 
 
Common underlying conditions associated with refractory breathlessness 
 
Breathlessness can have a significant impact on patients and carers, but hold different 
meanings based on diagnosis and progression of disease (M. Gysels & Higginson, 2011). 
Specific considerations based on those factors and also co-morbidities should be considered 
on an individual basis (Booth et al., 2014). However, research into the management of the 
effects of severe breathlessness, whatever the underlying condition, remains complex because 
of the limited number of studies and their power (Dorman et al., 2009). This is despite 
refractory breathlessness being recognised as the second most common symptom in patients 
with advanced chronic disease (Higginson et al., 2014). 
Chronic Obstructive Pulmonary Disease (COPD) 
 
The prevalence of COPD is increasing worldwide, accounting for more than three million 
deaths globally in 2015 (World Health Organization, 2016). COPD is a leading cause of death 
and disease burden (after heart disease, stroke and cancer) in Australia (Lung Foundation 
Australia, 2012), as well as being the second leading cause of avoidable hospital admissions 
(Glover, Page, Ambrose, & Hetzel, 2007). 
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Statistically in Australia, 7.5% of Australians aged 40 years or over have COPD with 
symptom progression that affects their daily lives. This increases to 29.2% of Australians over 
the age of 75 (Toelle et al., 2013).  
 
COPD is a disease characterised by recurring periods of acute pulmonary exacerbations, 
with a slow and gradual deterioration in health and a reduction in pulmonary function that 
gradually leads to death (Murray et al. 2005). The primary cause of COPD is tobacco 
smoking, either active smoking or the inhalation of second-hand smoke (World Health 
Organization, 2016).  
 
In a study of the frequency of general breathlessness in patients with COPD, 82% of the 
49,438 patients in a 2014 study reported dyspnoea using the Medical Research Council 
Dyspnoea Scale, indicating the high prevalence of breathlessness associated with COPD. 
Of this >40% of the patients reported moderate-to-severe dyspnoea (Müllerová, Lu, Li, & 
Tabberer, 2014), indicating refractory breathlessness. 
 
Some COPD patients require long-term oxygen therapy (Rabe et al.2007) to help manage the 
progression of the dyspnoea, but COPD affects more than just breathing. As the disease 
progresses it brings a myriad of other symptoms and issues associated with shortness of 
breath, such as anxiety due to the inability to comfortably breath (Booth, Silvester, & Todd, 
2003; M. H. Gysels & Higginson, 2009), social isolation and loneliness due to difficulty 
mobilising (Ek & Ternestedt, 2008), as well as issues around dependency (Ek & Ternestedt, 
2008) and the potential lack of meaningful activities in daily life (Williams, 1993). 
Cancer 
 
Breathlessness may worsen more rapidly in patients with cancer than COPD (Booth et al., 
2003) due to the nature of the underlying condition. Dyspnoea can occur with primary 
malignancy such as lung cancer or with a secondary cancer (Booth et al., 2014). Dyspnoea 
occurs in 90% of lung cancer patients (Booth et al., 2003) but is seen in 50-70% of other 
cancer patients with a marked increase in prevalence towards the end of life (Mercadante, 
Casuccio, & Fulfaro, 2000).  
Intractable breathlessness can often develop rapidly in cancer patients who may have felt 
relatively well. This can be very hard for patients and their carers as the decline can be seen as 
very quick, especially when comparing an activity that the individual may have previously 
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been able to easily complete, but is now unable to do so due to the acceleration of their 
breathlessness symptoms (Booth et al., 2008).  
As with COPD, management is complex and other factors including the individual’s cancer 
treatment more generally would need to be considered (Cachia & Ahmedzai, 2008). When 
cancer is advanced, the severity and complexity of an individual’s experience of dyspnoea 
should be considered alongside their disease status (Booth et al., 2008) and treated with a 
combination of drugs, oxygen and non-pharmacological interventions (Cachia & Ahmedzai, 
2008). 
 
Heart failure 
 
Heart failure is a chronic progressive cardiovascular disease with poor prognosis outcomes 
(Ryan & Farrelly, 2009). Breathlessness is the most prevalent symptom experienced by 
individuals with heart failure and often results in decompensation of the heart and recurring 
hospital admissions (Rich, 1999; Walthall, Jenkinson, & Boulton, 2017).  
Unfortunately even with optimal pharmacological management, those with advanced heart 
failure have a mean life expectancy of only 3.1 years (Levy et al., 2006). The degree of 
breathlessness experienced in this patient group can be linked to mortality and undiagnosed 
heart failure (van Riet et al., 2014) as well as acute decompensation (Mentz et al., 2015). 
Therefore the importance of understanding the dyspnoea and recognising its symptoms and 
multi-effects is vital for all health professionals in order to more effectively treat and support 
this patient group. 
 
Refractory breathlessness management 
Given its burden and prevalence globally, the symptoms of chronic refractory breathlessness 
remain under-treated. Individuals may feel they have to accept it as part of their disease, 
despite an evidence base for management  (Currow et al., 2014). Symptoms of breathlessness 
are more than just a physical feeling of being unable to get enough breath or being unable to 
breathe easily and confidently. Other factors such as patient support, anxiety and psychosocial 
issues and the individual perception of breathlessness are part of the individual make up and 
discussed below. A better understanding of severe or refractory breathlessness is needed in 
order to understand the depth of individual’s complex experiences (Booth et al., 2014). 
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Support network for chronically ill 
The role of a partner, carer, or family member assisting on a regular basis can make a 
profound difference to a person’s life when living with such a debilitating condition. Research 
shows family and carers play a vital role in patient care during palliation (Addington-Hall, 
2002). 
The cost on the carer, however, can have a significant impact on their life (Seamark, Blake, 
Seamark, & Halpin, 2004). In the case of refractory breathlessness, watching a loved one with 
severe breathlessness can be frightening. It is difficult to witness a loved one struggle to 
breathe (Booth et al., 2003). 
In one study by Booth et al. the role reversal for some patients and carers is discussed, as are 
the struggles for couples when the typical carer of the pair is now the individual being cared 
for (Booth et al., 2003). The significance of this study highlights the psychosocial complexity 
as well as the severity of the difficulties and struggles of the partner or carer as well as the 
patient. Carers are described as invisible victims as they helplessly watch, wait and feel 
anxiety while their partner struggles with his or her life and breath (Booth et al., 2003). 
Caregiver burden has been reported to be high, particularly among patients with cancer, heart 
failure and COPD (Garlo, O’Leary, Van Ness, & Fried, 2010). This study examined the 
caregiver burden over time caring for someone with advanced chronic disease. Correlations 
showed when caregivers reported they needed more help with daily tasks and emotional 
support, they also reported higher carer burden than those who didn’t feel they needed help in 
these areas (Garlo et al., 2010). Interestingly, carer burden has been found not to be disease 
specific but is a universal phenomenon across all three diseases where dyspnoea is a 
prominent symptom (Garlo et al., 2010). Interestingly, a carer support service is offered 
through an outpatient breathlessness clinic in London with promising results (Bausewein, 
Jolley, Reilly, Lobo, Kelly, Bellas, Madan, Panell, Brink, De Biase, Gao, Murphy, McCrone, 
& Higginson, 2012)  
Anxiety and breathlessness 
 
It is unclear if anxiety triggers breathlessness (Dudgeon & Lertzman, 1998) or breathlessness 
triggers anxiety (M. O'Driscoll, J. Corner, & C. Bailey, 1999), or if both could be true. But 
certainly anxiety can be linked to dyspnoea (Dudgeon & Lertzman, 1998; O'Driscoll, J. 
corner, & C. Bailey, 1999). One study refers to the ‘dyspnoea-anxiety-dyspnoea cycle’: a 
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feeling patients identify when they experience the anxiety not as a cause of breathlessness but 
rather as a sign of breathlessness or as a trigger to manage the breathlessness (Meek, 2005). 
The emotional vulnerability expressed as anxiety by some individuals in this study was a 
precursor of an episode of increased breathlessness approaching that they could not avoid 
(Meek, 2005).  
While interventions to enhance patients’ self-management of their breathlessness may not 
improve the intensity of immediate symptoms, they are likely to offer a greater sense of self-
mastery, reducing the fear, distress, anxiety and panic associated with refractory 
breathlessness, thus decreasing the often overwhelming symptom burden (Bausewein, Jolley, 
Reilly, Lobo, Kelly, Bellas, Madan, Panell, Brink, De Biase, Gao, Murphy, McCrone, & 
Higginson, 2012; Booth et al., 2008; Sherwood et al., 2005).  
People suffering refractory breathlessness often find they have hospital related admissions 
(Glover et al., 2007), yet many emergency admissions to hospital are initiated due to the 
anxiety associated with their dyspnoea (Glover et al., 2007). What’s more, end-of life 
refractory breathlessness may not be most effectively treated in hospital (Booth et al., 2008). 
Instead non-pharmacological interventions such as the use of a fan, anxiety reducing training, 
physical rehab (such as a breathlessness clinic can offer) and non-invasive ventilation can 
support better self-management (Booth et al., 2008; Davidson & Currow, 2010).  
In a study specifically looking at the COPD patient group, it was found that anxiety and 
depression were associated with higher levels of fatigue, shortness of breath, and frequency of 
COPD symptoms (Doyle et al., 2013). This study reported a correlation with breathlessness 
symptoms and reduced functional capacity that seemed to increase the frequency of anxiety 
and depression among this patient group. Those with refractory breathlessness could be at a 
risk of anxiety and depression due to their reduced capacity and functional activity. Further 
study is recommended to confirm these findings (Doyle et al., 2013). 
 
Individual descriptors of breathlessness 
 
Breathlessness is variously described by individuals. It possesses a number of different 
sensations and meanings to each individual describing their feeling of dyspnoea (P. Simon et 
al., 1990). Simon et al. developed a list of 15 descriptors of breathlessness that has been used 
in a number of studies exploring descriptors of breathlessness (Mahler et al., 1996; Wilcock et 
al., 2002), without a clear, distinctive or convincing pattern of description based on aetiology. 
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Within a group in Mahler et al’s study, 51% of COPD patients (n=85) described their 
breathlessness as, “my breathing requires effort”. This can be compared with Wilcocks’s 
study where 44% of COPD patients (n=34) described their breathlessness as, “I cannot get 
enough air”. Both studies used the same list of 15 descriptors. Of all the descriptors in the 
latter study, the most commonly used descriptor, irrespective of underlying condition, was, “I 
feel out of breath” (Lung cancer – pleural effusion and cardiac failure). 
The findings of these studies affirm the very subjective nature of breathlessness and how it is 
perceived by the individual experiencing it.  
 
Treatment methods for refractory breathlessness 
 
As management of refractory breathlessness is best done with a combined non-
pharmacological and pharmacological interventions approach (S. Simon & Bausewein, 2009), 
the need is evident for further exploration for allied health professionals engaged in treatment 
and research, particularly in relation to function and quality of life (Maddocks et al., 2014). 
The examples of studies linking refractory breathlessness with activities of daily living, 
including patients’ perspectives of daily activities and participation (Morgan & White, 2012), 
are limited.  
 
A systematic, evidence-based approach, combining the skills of a committed 
multidisciplinary team, would appear to improve the lives of these patients significantly 
(Booth et al., 2008). Booth et al. call for more research investigating the effectiveness of new 
interventions for more favourable management of this group, particularly non-
pharmacological interventions. 
 
Non-pharmacological treatment  
 
A number of non-pharmacological interventions exist in the current published literature, with 
varied levels of research quality. The Royal Australian College of General Practitioners 
(RACGP) list a number of interventions that could be considered for individuals suffering 
from severe dyspnoea. This does not consider the underlying aetiology, but only the 
symptomatic management of dyspnoea. Interventions mentioned include chest wall vibration, 
transcutaneous electrical nerve stimulation (TENS), walking aids, breathing techniques, 
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pacing and anxiety management (Wiseman, Rowett, Allcroft, Abernethy, & Currow, 2013). 
Pulmonary rehabilitation and the use of a handheld fan are discussed below.  
 
Pulmonary rehabilitation 
 
Pulmonary rehabilitation has proved to be highly beneficial for patients suffering from 
chronic breathlessness (Nici et al., 2006; Ries et al., 2007). A variety of benefits have been 
reported to improve functional abilities such as a reduction in shortness of breath during 
exercise as well as improving exercise tolerance (Bianchi et al., 2011; Nici et al., 2006; Ries 
et al., 2007; Stulbarg et al., 2002; Troosters, Casaburi, Gosselink, & Decramer, 2005). 
Participants also report they struggle with their dyspnoea less when engaging in a pulmonary 
rehabilitation program (Parshall et al., 2012).  
The primary purpose and benefit of pulmonary rehabilitation are the improvements 
participants can achieve in their exercise abilities (Bianchi et al., 2011; Gigliotti et al., 2003; 
O'Donnell, McGuire, Samis, & Webb, 1998; Stulbarg et al., 2002). It is still unclear, however, 
if the improvements in dyspnoea are due to improvements in conditioning, learning and 
applying pacing of activities, or whether participants become more desensitised to the varied 
respiratory sensations experienced on exertion during the program, or a combination of a 
number of the listed factors (Parshall et al., 2012).  
Generally patients have other influencing aspects of their care when enrolled in a pulmonary 
rehabilitation program. These may include education from health professionals - including 
allied health - medication management, pacing of activities and breathing techniques that all 
contribute to the improvements alongside the exercise program (Parshall et al., 2012). 
One study that did examine the role of occupational therapy (OT) in pulmonary rehabilitation 
(PR) for COPD patients showed promising results, identifying the value OT plays to improve 
patient outcomes (Lorenzi et al., 2004). This was done by measuring the number of functions 
lost using the Basic Activity of Daily Living (BADL) categories before and after 
rehabilitation. Aiming to establish whether PR plus OT - as opposed to just OT - has the 
potential for improvement for patients’ daily activities, results showed patients in the PR+OT 
group had a significant improvement in BADL after the programme (Lorenzi et al., 2004). A 
further step would be to identify how such patients perceive their breathlessness and how it is 
affecting their lives. 
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The handheld fan 
 
A hand-held fan is a simple, manageable aid to relieving breathlessness for individuals 
suffering from dyspnoea. It is practical, cheap and easy to use at home or out and about, and 
does not have adverse side effects (Booth et al., 2008). An intervention that the individual can 
initiate at a time of their choosing and manage themselves promotes self-efficacy, something 
important to this group given that severe breathlessness is not easily controllable (Carrieri-
Kohlman, 2006).  
 
It has been reported that for the individual using the fan, a flow of air to the face, nasal 
mucosa, or pharynx may alter ventilation and relieve breathlessness (Schwartzstein, Lahive, 
Pope, Weinberger, & Weiss, 1987).  
 
A randomised controlled crossover trial praised the benefits of the handheld fan supporting 
the hypothesis that a handheld fan directed at the face can reduce the sensation of 
breathlessness (Galbraith, Fagan, Perkins, Lynch, & Booth, 2010). Patients perceive the fan 
as one of the most important treatment strategies for the management of refractory 
breathlessness (Booth et al., 2014).  
 
One study withheld a definitive conclusion on the efficacy of the handheld fan (Bausewein, 
Booth, Gysels, Haberland, et al., 2010), but given the distress patients suffer, and the positive 
reports from literature, it seems worth considering a simple, inexpensive intervention that has 
no ill effects and might reduce suffering (Galbraith et al., 2010). 
 
In the current published literature, no large clinical trials have yet examined the use of 
handheld fans for the relief of breathlessness in patients (Marciniuk et al., 2011; Parshall et 
al., 2012).  
 
Pharmacological treatment 
 
Studies investigating the use of pharmacological treatment such as opioids, oxygen and 
anxiolytics have published promising findings (A. Abernethy et al., 2003; Booth et al., 2008; 
Ferreira et al., 2016; Martins et al., 2016). It is reported that currently limited evidence 
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supports the routine use of a number of pharmacological drugs such as: benzodiazepines, 
antidepressants, phenothiazines and inhaled furosemide (S. Simon & Bausewein, 2009). 
Oxygen and opioids have more substantial research and are elaborated below.  
 
Oxygen 
 
Booth et al. published an influential paper showing both cylinder oxygen and cylinder air can 
significantly improve breathlessness for hospice patients suffering from cancer (Booth, Kelly, 
Cox, Adams, & Guz, 1996). Abernethy et al. studied the use of oxygen vs. room air via a 
concentrator using a nasal cannula, at a rate of 2L per minute for a minimum of 7 days. The 
results suggested that patients found symptomatic relief from both methods, but with no 
significant differences between them (Abernethy et al., 2010).   
 
Interestingly, in the evidence-based management guidelines from The Royal Australian 
College of General Practitioners (RACGP), oxygen therapy does not have sufficient support. 
The guidelines acknowledge it is widely used for dyspnoea but note that this is often with 
little reference to the individual’s partial pressure of oxygen or pulse oximetry (Wiseman et 
al., 2013). 
 
Opioids 
 
The use of oral morphine administered on sustained release at low dosage provides significant 
symptomatic improvement in refractory dyspnoea in a community setting, supporting 
individuals in their general struggle with dyspnoea as well as bringing improvements around 
quality of sleep (A. P. Abernethy et al., 2003). It is also reported that opioid use in 
breathlessness is most effective in management of non-malignant disease (A. Abernethy et al., 
2003; Jennings, Davies, Higgins, Gibbs, & Broadley, 2002). The study by Abernethy et al. 
has significant rigour as a randomised, double blind, placebo controlled crossover trial. The 
only negative reported association were the side effects from the morphine that some 
participants found challenging, including severe constipation. However the study notes it was 
not empowered to address side effects. The above studies note the need to explore further how 
treatment outcomes make a difference to individual experiences of breathlessness.  
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Refractory breathlessness vs. pain 
 
After pain, refractory breathlessness is reported as the second most common symptom in 
patients with advanced chronic disease (Higginson et al., 2014). Like pain, refractory 
breathlessness is an experience arising from complex, non-static interactions between 
emotional, physiological and pathological elements (Higginson et al., 2014). 
 
Therapeutic advances in the clinical management are limited and refractory breathlessness 
remains difficult to treat successfully, especially in advanced stages (Booth et al., 2008; 
Davidson & Currow, 2010). However, as reported by Currow et al. patients’ access to 
adequate pain relief is now accepted as a human right. Given the burden of refractory 
breathlessness globally, the symptomatic treatment of this condition should be seen in exactly 
the same way as pain (Currow et al., 2016). 
 
In addition, palliative patients, particularly with COPD, can benefit from better management 
of breathlessness, including improved pain management (Solano, Gomes, & Higginson, 
2006). This suggests that in cases of prognostic uncertainty, palliative care should be made 
available on the basis of need assessed on the presenting symptoms, rather than on prognosis 
only (Solano et al., 2006). 
 
Refractory breathlessness in a breathlessness clinic setting 
Studies have shown breathlessness clinics offer significant benefits in supporting individuals 
with severe breathing difficulties from an underlying chronic condition. For example, a newly 
established clinic specifically for lung cancer patients measured the benefits of the support 
they offered. The study produced very promising results when the percentage of patients 
experiencing breathlessness several times or more per day was reduced from 73% to 27% four 
weeks later (Hately, Laurence, Scott, Baker, & Thomas, 2003). Beyond physical 
improvements, the study demonstrated significant improvements in quality of life with 
patients being freer to do more of the things they wanted (Hately et al., 2003). 
This clinic was led by a senior physiotherapist experienced in chronic dyspnoea management. 
Interventions offered during this study were very positively received. Interventions offered 
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over a period of 4-6 weeks included breathing retraining, basic relaxation techniques, activity 
pacing and psychosocial support. The success of this 2003 study by Hatley et al. mirrored two 
previously reported successful studies (Bredin et al., 1999; Corner, Plant, A'Hern, & Bailey, 
1996), emphasising the benefits of a breathlessness clinic with significant breakthroughs in 
the management of dyspnoea both in regard to symptom control and improvements in 
psychological wellbeing. It’s noteworthy to mention all three studies focused on lung cancer.  
Similar results were seen in a randomised controlled trial by Higginson et al (2014) which 
looked at the experiences of patients with advanced disease and refractory breathlessness, 
comparing those receiving support through a breathlessness clinic with those receiving more 
usual care. Results suggested that patients did benefit from a dedicated palliative care 
breathlessness clinic setting. Benefits included improved management, decreased fear, 
anxiety, worry and panic, and greater confidence (Farquhar et al., 2014; Hately et al., 2003).  
A bottom line benefit also found breathlessness clinic settings reduced the care costs of 
patients compared to standard care (Farquhar et al., 2014).  
Studies have found breathlessness support services aim to provide patients with strategies and 
interventions to help them master their breathlessness, while accepting that the disease cannot 
be cured (Bredin, 1999; Corner et al., 1996; Hately et al., 2003; Higginson et al., 2014). Thus, 
the amount of perceived breathlessness mastery is probably a more important component of 
quality of life than is the amount of actual breathlessness itself (Higginson et al., 2014).   
 
Qualitative study methods for refractory dyspnoea palliative care patients  
When undertaking research with individuals suffering significantly on a daily basis, all 
measures need to be considered to ensure best possible practice is followed for the patients 
and for their carers. Undertaking research within a palliative care context can be challenging 
(Addington-Hall, 2002). Considerations include ethical, practical, methodological and 
emotional issues for potential participants, family and carers (Addington-Hall, 2002; Ewing et 
al., 2004).  The ethical principles of the Declaration of Helsinki for human research ethics 
(World Medical Association, 2013) is the guiding cornerstone. As discussed, ethical approval 
has been granted for this study. Strict procedures have been followed to ensure this project is 
ethical, treating participants with unreserved respect and dignity.  
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The National Cancer Research Institute Palliative Care Breathlessness Subgroup supports 
qualitative study methods via unstructured or semi-structured interviews when researching 
breathlessness (Dorman et al., 2009). Furthermore, qualitative research gathering patients’ 
and carers’ experiences offers an extra dimension of understanding for a multi-disciplinary 
treating team (Dorman et al., 2009).  Information such as this is not easily available via a 
quantitative study (Booth, Farquhar, Gysels, Bausewein, & Higginson, 2006; Booth et al., 
2003). 
Given the bleak prognosis of refractory breathlessness participants in any study, the potential 
to improve their remaining quality of life with evidence-based interventions and coping 
strategies (Booth et al., 2006) remains significant (Currow et al., 2016; Currow et al., 2010). 
This is particularly so in the context of management within a breathlessness clinic setting 
(Farquhar et al., 2014). 
 
Conclusion  
 
In a 2010 Australian study, Davidson and Currow point to a significant disparity between the 
prevalence and severity of refractory dyspnoea and sufficient data to adequately inform 
evidence-based guidelines (Davidson & Currow, 2010).  Those authors call for increased 
research to address the specific burden of refractory breathlessness symptoms. 
 
Through an extensive review of the current literature of refractory breathlessness, it is clear 
that aspects of the pathophysiology, management and treatment have improved in recent 
times. However chronic refractory breathlessness remains significantly undertreated despite 
the prevalence, severity and chronicity of this symptom and an evidence base of affordable 
and safe interventions (Currow et al., 2014; Parshall et al., 2012). 
 
As Currow et al. state, it should be a human right for patients with refractory breathlessness to 
be adequately treated (Currow et al., 2014). Pain control and management is now considered a 
human right (Brennan, Carr, & Cousins, 2007; Lohman, Schleifer, & Amon, 2010)  The 
treatment of refractory breathlessness should be viewed and managed in the same way 
(Currow et al., 2016). 
 
Studies linking refractory breathlessness with activities of daily living, including individual 
perspectives of daily activities and participation, are limited (Morgan & White, 2012), but it is 
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noted that people with advanced disease continue to strive for ongoing participation in 
everyday life to the best of their ability, irrespective of the profound symptoms of 
breathlessness they may be experiencing (la Cour, Johannessen, & Josephsson, 2009; Lyons, 
Orozovic, Davis, & Newman, 2002; Svidén, Tham, & Borell, 2010).  
 
Further research exploring the experience of refractory breathlessness for individuals, how it 
affects their functional capacity and engagement in daily life, and where interventions would 
be most supportive, would be highly beneficial for those directly and indirectly affected, 
adding to the current body of literature.  
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The Lived Experience of Refractory Breathlessness  
Abstract  
 
Introduction: Refractory breathlessness is breathlessness at rest or on minimal exertion that 
persists chronically even with optimal treatment of the underlying cause. Despite its burden 
and prevalence globally, symptoms remain under-treated and under-researched and those 
affected struggle daily with the condition.  
Aim: The aim of the study was to gain a greater understanding of the lived experience of 
refractory breathlessness. Also, it was anticipated that a deeper insight into its impacts on 
daily activities would allow more effective occupational therapy interventions to be 
developed.  
Method: A qualitative phenomenological approach using NVivo software, with one-on-one, 
semi-structured interviews and themes established through thematic analysis. The study 
recruited consecutive patients until thematic saturation was reached. Participants were 
recruited from a Sydney-based outpatient Breathlessness Clinic at a palliative care hospital.  
Results: 6 participants were interviewed and 4 main themes identified. 1) Living on the Edge, 
referring to the extreme feeling of breathlessness experienced by patients; 2) Social Needs, 
describing the significance of social support; 3) Reduced to the Basics, referring to the effect 
breathlessness has on basic daily tasks, and 4) Sources of Security, which describes the 
measures participants take to protect themselves from their own breathlessness. For each of 
the four themes, three to five subthemes were also identified through the analysis.  
Conclusion: Of the 4 themes identified in this study, number 3 and 4 may represent the best 
targets for occupational therapy interventions. Patients noted the importance of functional 
participation for improved engagement and quality of life. There is scope to develop specific 
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interventions for self management and equipment prescription given lack of published 
literature in this area.  
 
MeSH terms: dyspnea, occupational therapy, chronic obstructive pulmonary disease, 
activities of daily living, palliative care. 
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Background 
 
Breathlessness, also known as dyspnoea, is commonly associated with advanced chronic 
disease and is significantly debilitating (Currow et al., 2014). Breathlessness occurs in up to 
94% of people with advanced Chronic Obstructive Pulmonary Disease (COPD) and 70% of 
patients with lung cancer (Blinderman, Homel, Andrew Billings, Tennstedt, & Portenoy, 
2009; Currow et al., 2010; Solano et al., 2006). As the underlying disease progresses, the 
severity of breathlessness also increases, causing considerable distress and feelings of panic 
for people with breathlessness and their families (Higginson et al., 2014; Seow et al., 2011). 
 
Breathlessness has a significant impact on individuals and their carers but is likely to be 
experienced differently due to a number of factors including the underlying diagnosis and 
disease progression (Currow et al., 2010; M. Gysels & Higginson, 2011). The cause of 
breathlessness will also influence its management and intervention (A. Abernethy et al., 2003; 
Currow et al., 2010) 
 
Refractory breathlessness is the most crippling form, and is characterised as “breathlessness at 
rest or on minimal exertion that will persist chronically despite optimal treatment of the 
underlying cause(s)” (Currow et al., 2014). Refractory breathlessness patients have a variety 
of fluctuating emotional, physiological and pathological factors that require considerable 
management, in some cases in a palliative care setting. (Higginson et al., 2014).   
 
Given its burden and prevalence globally, the symptoms of chronic refractory breathlessness 
remain under-treated and individuals may feel they have to accept it as part of their disease, 
despite an evidence base for management  (Currow et al., 2014). Studies investigating the use 
of pharmacological treatment such as opioids, oxygen and anxiolytics have published success 
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(A. Abernethy et al., 2003; Booth et al., 2008; Ferreira et al., 2016; Martins et al., 2016). 
These studies note the need to explore further how treatment outcomes have made a 
difference to individual experiences of breathlessness.  
 
As management of refractory breathlessness is best done with a combined non-
pharmacological and pharmacological interventions approach (S. Simon & Bausewein, 2009), 
further investigation of the potential contributions of allied health professional interventions 
such as occupational therapy is needed.  Examples of studies linking refractory breathlessness 
with activities of daily living, including individual perspectives of daily activities and 
participation, are limited (Morgan & White, 2012).  
 
The implications and the experiences of refractory breathlessness are currently under-studied 
and also present as an unmet palliative care need (Currow et al., 2016; Currow et al., 2010; 
Dorman et al., 2009; Maddocks et al., 2014). This is despite COPD being a major cause of 
refractory breathlessness. COPD is also a leading cause of death and disease burden (after 
heart disease, stroke and cancer) in Australia (Lung Foundation Australia, 2012), and is the 
second leading cause of avoidable hospital admissions (Glover et al., 2007). 
 
Therefore, this study aims to contribute to a better understanding of the experience of 
refractory breathlessness from the perspective of people experiencing it. This will allow 
further insight into the impacts of refractory breathlessness on daily activities and more 
effective interventions to be considered, including those around daily occupations. 
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Methodology 
 
Ethics 
 
This study was conducted in a partnership between the University of Sydney and 
HammondCare Greenwich Hospital. 
 
The research project was granted ethical approval (LNR/17HAWKE/154) from NSW Health 
through the Northern Sydney Local Health District (NSLHD) research office Human 
Research Ethics Committee (HREC) and the HammondCare Research Governance Body and 
HammondCare Steering Committee. Patients were provided with an information and consent 
form prior to participation in the study and were required to provided written and verbal 
consent prior to interview.  
 
Study design 
 
This exploratory qualitative study used a phenomenological approach (Lindseth & Norberg, 
2004) focusing on a personal lived experience (Polgar & Thomas, 2013) of refractory 
breathlessness. A phenomenological approach allows an understanding of the meaning of a 
phenomenon within the unique experience of participants. This study focused on the 
individual experience of refractory breathlessness and how it affects the everyday lives of 
study participants.  
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Participants 
 
Participants were recruited by the medical team at the HammondCare Breathlessness Clinic 
and verbally offered the opportunity to participate in the study. Patients were informed that 
their decision to participate would not affect their care from the Clinic. 
  
The target population for this study were men and women living with refractory 
breathlessness. The inclusion, exclusion and withdrawal criteria were as follows: 
 
Inclusion Criteria 
- Diagnosis of refractory breathlessness by the Breathlessness Clinic.  
- Over 18 years of age 
- Able to converse in English 
- Able to independently attend the Clinic at Greenwich Hospital and considered fit to 
participate in an interview by medical staff  
Exclusion Criteria 
- Unable to converse in English 
- Medically excluded by staff at Greenwich Hospital 
Withdrawal Criteria 
- Participant choice 
- Symptoms becoming too severe 
 
The study was reliant on the numbers of patients being treated at the Breathlessness Clinic 
during the recruitment phase of the study.  
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Data collection  
 
Four participants were interviewed at the Breathlessness Clinic, Greenwich Hospital, and the 
remaining two were interviewed in their homes, due to an exacerbation of symptoms and 
inability to travel easily. The interviews took place between July and September 2017, were 
face-to-face semi-structured, lasting between 29 and 39 minutes using an interview schedule. 
Interview topics covered areas such as diagnosis and disease progression, experience of 
breathlessness, typical day description, activity participation, rest and sleep, carer support and 
social relationships, spiritual support and self-care, and how they manage their breathlessness 
at this stage in their disease progression.  
 
All participants had refractory breathlessness and some had difficulty talking, therefore time 
was taken to accommodate their needs individually. The interviews were voice recorded and 
transcribed verbatim, with additional observations and field notes recorded. The purpose of 
the interviews was to gain each individual's perspective on how refractory breathlessness 
affects their everyday life. The interviewer explored how the breathlessness affected different 
areas of each person’s life. 
 
Data analysis 
 
The aim of the thematic analysis was to gain greater understanding and interpretation of the 
lived experience of the participants (Polgar & Thomas, 2013),  
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Two-stage coding was used to analyse the data (Saldaña, 2012). The first stage summarised 
segments of data line by line. The second stage grouped the findings into fewer categories to 
analyse and establish clear themes and sub themes with consensus cross checking. Nvivo 
software was used to manage the data.  
 
 
Results 
 
A total of six participants were recruited and interviewed until thematic saturation was 
achieved, as summarised in Table 1. Participants presented at their individual interviews with 
varying levels of breathlessness. Some were concerned about their capacity to participate and 
required specific details of the location of the interview room to determine if they could 
manage the walking distance and the possible effect on their breathlessness. Participants were 
all offered explicit opportunities to take a break whenever they needed it in order to calm their 
breathing.  
 
Four main themes and fifteen subthemes were established from the thematic data analysis, 
outlined in table 2.  
 
Theme 1: Living on the edge  
 
All participants described some level of how precarious their overall life situations were 
because of their breathlessness. This was expressed in relationship to the immediacy of 
feeling breathless. For instance, one participant stated:  
 
“When you can't breathe, nothing else matters.” (P3) 
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This poignant statement expresses the feelings accompanying breathlessness and 
demonstrates the profound impact on quality of life because of it. Participants feel they are 
living on the edge, consumed and controlled by their breathlessness and the limitations it 
causes in their lives. 
 
Experiences of not being able to breathe  
 
Some participants (identified here by Participant number, as P1- P6) described feeling as 
though they were being deprived of breath to the point they may not survive being seriously 
breathless. They also described the fear associated with panicked breathlessness and the 
vicious cycle it triggers of being unable to catch their breath: 
 
 “Sometimes you feel like you are suffocating.” (P6) 
 
“When it gets bad enough, I feel that I'm not going to get enough air and I'm going to 
die.” (P2) 
 
 “You can't breathe deep enough.” (P3) 
 
While participants described their breathlessness individually, a common theme was of 
feeling they were living in a heightened state of awareness around their inability to 
comfortably take a breath.  
 
Participant 4 described his breathlessness as a totally overwhelming experience that can come 
over him simply by doing a basic activity such as trying to walk 30m to his vehicle: 
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“Just an extreme case of breathlessness. I lose all my strength and I become very 
breathless.”  (P4) 
 
Participant 6 indicated that it would be hard to let anyone else know about her distress when 
breathless: 
 
 “I can't even get through a sentence without huffing and puffing.” (P6) 
 
Adapting to breathlessness 
 
To function day to day, participants made changes in their lives to manage their 
breathlessness. This required a lot of thinking about alternatives and learning from experience 
how to preserve a way of living that was at least somewhat satisfying or sustainable. Each 
person adapted in different ways based on their personal health, social support and living 
circumstances. Doing things slowly was a common strategy. For instance: 
 
“There's a great deal of learning involved once one develops this sort of thing 
 [breathlessness] because one wants to learn what is the best way of living with it and 
still having some sort of life. So I've learned to do things slowly, for example.” (P5) 
 
“I have to really do everything slowly, I mean, I might get my underwear on and a 
pair of  pants or something and then I've got to stop and breathe.” (P2) 
 
Frustration with breathlessness 
 
Five of the six participants expressed frustration around their breathlessness and the 
limitations that come with it. Many talked about being debilitated by their condition that 
prevented them from engaging in occupations they enjoyed or were important. For example, 
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they spoke of feeling very frustrated because they can’t do simple tasks such as walking to 
their car without becoming breathless. They also noted the frustration associated with the 
inability to plan an outing with friends without needing to know all the details in case factors 
would make their breathlessness worse.  
 
“I just feel really teed off that I have got this problem even though I realise it’s mine, 
my fault. I’ve always been extremely fit, outdoors sort of a person and now I’m 
limited.” (P1) 
 
“I am sort of almost angry that I’m in this situation.” (P1) 
 
One participant stated that she couldn’t afford to get frustrated because it made things worse, 
so she denied her frustration: 
 
“No, because I very deliberately don't let it ... Because if I became frustrated I would 
become breathless.” (P5)  
 
This statement indicated her awareness of the potential for frustration. It also expressed her 
efforts for self-preservation and her need to maintain some control in her situation despite the 
restrictive reality of her breathlessness.  
 
Theme 2: Social Needs and Support 
 
Social support was a significant factor for a number of participants managing their underlying 
disease as well as breathlessness. They described how much they rely on their family or 
partner for daily support, and also their fear as to what they would do if they didn’t have this 
support in place helping them cope. This was expressed by all participants, except one. The 
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sole participant living alone and not in a relationship viewed her social support needs 
differently. She felt comfortable on her own because she didn’t need to consider anyone else’s 
needs:  
 
“Because I'm virtually on my own I think, in a way, although it's sort of lonelier for 
company, but I've more freedom in that I don't have to accommodate someone else.” 
(P3) 
 
Social support was, however, seen by the other participants as vital for those unable to do 
daily self-care tasks easily and freely. Some participants reflected on what care they might be 
receiving if they didn’t have a supportive family. For instance: 
 
“If I didn't have family support I doubt ... I mean I'd have to be in some sort of 
assisted place anyway.” (P4)  
 
Pragmatics of getting out 
 
Participants described the planning and practical considerations of leaving the house, and how 
these had become increasingly difficult as they attempted to manage their breathlessness. 
Essential medical appointments were mentioned as a necessity but difficult to plan and attend 
at times due to the physical burden of their breathlessness.  
 
“So medical appointments ... Well actually, yes, it has been a pest at times, thinking I 
probably need to go to the GP but it'll be a bit awkward getting there, even in the car, 
because I'm breathless.” (P5) 
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Social outings were planned based on several factors including familiarity of location that 
offered predictability when considering walking distance, parking ease, waiting time and the 
physical environment. These considerations limited the choices participants made, for 
instance: 
 
“…we have to discuss whether there's stairs, how far I have to walk, um, all this has 
to be done before I can even think about saying yes to anything.” (P2) 
 
 
A number of participants relied on their social support networks to drive them to 
appointments, social engagements and to access the community. This support assisted those 
participants to actually leave their home which for some was a significant event. Some 
described a physical struggle leaving the house that was sometimes impossible without help. 
 
For one participant, even small distances are a challenge:  
 
“Just getting from the house to the car, I have to stop usually twice before I can get to 
the car. Sometimes I get down the stairs and then I've got to rest on the bloody bin to 
breathe.” (P2)  
 
This 20-metre walk from her front door to her car caused significant breathlessness and was 
an on-going struggle each time she went out. 
 
Another participant described how his declining health meant that he had lost the desire to 
socialise. The idea of trying to go out was unappealing due to logistical considerations 
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because his physical limitations were becoming more difficult. He felt it was easier just to 
stay at home, despite the risk of social isolation: 
 
“You just don't feel like socialising too much any more you know, and it's because of 
all those things you know you have to think of distance, walking, and, you know, get 
uncomfortable even sitting down in the one spot, so there's all these things that will 
affect your mood and your lifestyle definitely. It has an enormous impact. It's easier 
just to stay at home.” (P4) 
 
“I have no real social life any more.” (P2) 
 
Effect of breathlessness on relationship with others 
 
Refractory breathlessness not only affects the patient but also those around them. Watching a 
loved one gasp for breath was described as distressing for her partner by one participant. She 
felt her condition was a dreadful thing to witness:  
 
 “He's seen me in extremis and panting a bit, so it must be ghastly. I mean, it's nasty 
 putting up with it, but it must be pretty terrible looking at somebody.” (P5) 
 
Having a supportive relationship was mentioned as a coping strategy. One participant, 
however, described how her husband didn’t understand her breathlessness. This clearly was 
very distressing for her and his lack of understanding had a negative effect on their 
relationship. 
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“I think he's in denial. He doesn't feel I'm all that sick… He feels that I'm getting 
lazy… He gets cranky and agitated easily with me if I walk from one [place] to the 
next and I have to stop. He gets annoyed.” (P2) 
 
While all participants spoke openly during interviews, one disclosed how she consciously 
chose to protect her privacy around her condition from friends and family, aside from her 
husband. She does not share details of her severe COPD, instead referring to it as “this bloody 
chest thing”. (P5) 
 
Theme 3: Reduced to the basics 
 
Participant 4 described his current activity capacity as reduced to “just the basics of life”. He 
is so unwell and breathless the activities he used to do such as paid work, mowing, socialising 
or driving are now impossible. He feels defeated that he has such a reduced capacity and how 
it affects all aspects of his life. 
 
“If you can't breathe, you can't walk, you can't do anything. You can't swim, or ... All 
the things you'd like to do, you can't do them anymore.” (P4) 
 
Adjusted capabilities 
 
To maintain meaningful participation in even basic activities, participants had to adjust their 
personal expectations of what they could achieve. They needed to come to terms with their 
reduced capacity and what they could expect of themselves, or what meaningful occupations 
they could participate in. Participants reflected on what they had lost as a result of their 
breathlessness. For instance: 
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“I’ve always been extremely fit, outdoors sort of a person and now I’m limited.” (P1). 
 
One participant described that adjusting to their capabilities meant that they experienced 
breathlessness without gaining anything or without any participation. 
 
“And that is really so, so, so overwhelming because you're gasping for breath over 
[doing] nothing.” (P3) 
  
Capacity to undertake Activities of Daily Living (ADLs) 
 
The breathlessness experienced by participants affected basic ADL activities.  
 
 “Even though I've been on oxygen all night, I'm breathless as soon as I get up to go 
to the toilet.” (P2) 
 
“So I sit on the toilet to do on my breathing technique before I can go any further to 
help me through that.” (P2) 
 
Activities that were limited included cleaning, dressing, showering and using the toilet.  
 
“Showering and dressing are a real, a real task, yeah.” (P2) 
 
 
“I have to really do everything slowly, I mean, I might get my underwear on and a 
pair of pants or something and then I've got to stop and breathe.” (P2) 
 
Participants described their struggles but also their initiatives to adapt, pace themselves or use 
breathing techniques and self-talk to cope with their reduced capacities and try to meet their 
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basic care needs. Patients mentioned sitting to dress, cleaning for 10-minute bursts and 
slowing the pace of tasks down to accommodate their breathlessness. 
 
" So I've got to do the cleaning over a few days” (P3)  
 
“I get a few steps and I've got to sit. And I just feel it's not worth it. I try to push 
myself, but it's just not happening.” (P2) 
 
(Self talk) “Hey [participant name], do the proper sort of breathing- ‘in’: smell the 
roses and blow out over the sea.” (P1) 
 
Psychological distress 
 
Participants openly spoke about their growing realisation that their daily lives were more 
difficult because of their refractory breathlessness and the psychological toll this has on them. 
Emotions and psychological impact were expressed differently by all participants but each 
voiced negative associations with the condition. For instance: 
 
“I have always been a happy person, but I think I am probably less happy now.” (P1) 
 
Participant 5 described panic when experiencing breathlessness: 
 
“Once you panic, you panic more, and then you become more breathless so you panic 
more. Ghastly. Truly ghastly.” (P5) 
 
Pacing 
 
A number of participants spoke about the need to pace their level of activity to manage basic 
tasks. They also discussed their worries about over-exerting themselves, then causing 
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breathlessness that could lead to panic, making it worse. This meant adapting to not being 
able to do things at their previous “normal” pace. For instance: 
 
“But if I did things at my normal pace, what used to be my normal pace, I would get 
breathless, and then the worst thing is to panic.” (P5) 
 
There were consequences for the participants if they did not pace themselves to meet their 
capacity level for activity: 
 
“There are a lot of things I can't do. And I'm aware that if I move too quickly I'm 
likely to become more breathless.” (P5) 
 
“I end up doing things and then I get really puffed and think oh, I forgot, I'm 
supposed to have a rest.” (P6) 
 
Sleep and rest 
 
Varied responses around sleep were reported. A number of participants had sleeping 
limitations such as sleeping positioning and perceived poor quality of sleep. Several reported 
that they sleep propped up with pillows or sitting up on a sofa to prevent breathing 
difficulties. Some report taking pharmacological drugs such as OxyNorm with sleeping 
tablets or Panadeine Forte to aid restful sleeping. Positioning was mentioned a number of 
times to ease the struggle to sleep. 
 
“Sometimes during the night if I sleep, I sort of sit, sleep, semi-sitting up.” (P4) 
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“And it didn't matter what I took, um, nothing helped the pain and a girlfriend gave 
me a Panadeine Forte and one night I took it and it was the best sleep ever.” (P6) 
 
“I've got to sit up on five pillows to sleep. And that’s horrible.” (P3) 
 
Theme 4: Sources of security  
 
A number of the participants used interventions, equipment or limited themselves to familiar 
settings to offer security to manage their breathlessness. Their need to have some security in 
case they became more breathless influenced their actions and decisions.  
 
Handheld fan 
 
One participant described his handheld fan as “just incredible” (P1). So much so, that he 
preferred to rely on this rather than his home oxygen supply when he felt breathless. It gave 
him confidence to help manage his breathlessness.  
 
Another patient anticipated the benefits of using a handheld fan due to its mobility and 
convenience:  
 
“I think it [the handheld fan], makes me ultimately a bit more mobile, just from 
having confidence that I'll know if I get breathless I can whip out a little thing and 
get a blast of cold air on my face.” (P5)  
 
This participant perceived that the handheld fan would enable her to be more mobile and 
offered her added security that she would be able to get her breath back if she became 
breathless.  
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Equipment to help with coping 
 
Certain types of equipment offered a way of coping for the participants: portable oxygen, 
home oxygen, CPAP machine, face masks, or a long-handled reacher.  One participant spoke 
about the certainty of knowing oxygen was available at venues should it be required. Another 
mentioned keeping portable oxygen in her car to offer reassurance if she needs it. She said: 
 
“I don't think I need it but I'm too scared to give it up just in case, it's a security.” 
(P6) 
 
 
The use of a face mask in public allowed participants to reduce the risk of infection, 
particularly in crowded places or when coughs and colds become more prevalent. For 
instance: 
 
“Better I be sort of protected than copping someone's germs because when I'm sick, 
I'm sick for, say, like three weeks, sitting up, just to sleep.” (P3) 
 
Feelings of security influencing social outings 
 
Participants reflected that having familiar measures in place acts as a source of security when 
they are out in public. One woman described knowing that trained staff at a frequently visited 
venue could help if medical treatment was needed. That offered her peace of mind. She has 
not required that help, but knowing it is available was reassuring. This patient also mentioned 
that the distance to the hospital from the venue was closer than from her home. These details 
gave her “comfort” (P2). 
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Comforting or encouraging self-talk seems to offer some protection against the increasing 
powerlessness of refractory breathlessness.   
 
 
Discussion  
 
Individual personal experiences of refractory breathlessness are not well studied, particularly 
from an allied health occupational therapy perspective that focuses on enabling participation 
in everyday activities to the best of the individual’s abilities (Morgan & White, 2012). The 
purpose of this study was to investigate the experience of refractory breathlessness from 
individuals’ own perspectives and to describe how they perceived this affected their daily 
lives. The results of this study show that refractory breathlessness significantly impacts the 
daily lives of participants and their families, including physical capacity, mood, sleep, routine, 
social contact and feelings of security and, in turn, the functional capacity of individuals 
which has a significant effect on participation and quality of life. 
 
The themes identified clearly indicated the severe limitations refractory breathlessness brings. 
Similar themes have been explored in studies of individuals with COPD and heart failure. 
Findings included the perception and severity of breathlessness and the accompanying fear, 
panic and anxiety it generated (Barnett, 2005b). Living in fear of their disease was also 
highlighted in a study examining the experience of people with heart failure (Ryan & Farrelly, 
2009), noting the profound impact this had on participation in daily life.  
 
Of particular importance to occupational therapy are themes 3 and 4 which deal with 
functional and psychological limitations of refractory breathlessness on quality of life and 
activities of daily living.  
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These themes have also been highlighted by other research groups. One study noted that as 
the disease progresses with COPD patients, basic daily tasks become harder (Barnett, 2005a). 
The use of assistive devices such as home oxygen were mentioned as an important resource 
by this group but findings are mixed with a study by (Ek, Sahlberg-Blom, Andershed, & 
Ternestedt, 2011) noting that while home oxygen assists with relieving breathing difficulties 
it can also be a limitation. Some patients could not mobilise the tank independently, making 
them more inclined to stay home, risking isolation. One participant in this study requiring 
home oxygenation expressed this concern. 
 
The goal for people with refractory dyspnoea is not curative but rather to increase their levels 
of control over their condition and functional engagement. This improves their confidence 
and self-worth through participation in daily life. Participants in our study have all 
independently initiated or learned self-management behaviours from the Breathlessness Clinic 
such as adapting activities, pacing, self-talk, and utilising social support. These behaviours 
have been previously reported for patients with chronic respiratory illness (Apps et al., 2014). 
Pacing, for example, has been described as a beneficial adaptation to conserve energy, 
enabling more effective participation in daily activities (Apps et al., 2014). The benefits in 
self-management of chronic disease reflect the Australian Government’s Sharing Health Care 
Initiative. This includes positive psychological and physical benefits from increasing the 
knowledge base of people with this condition, supporting self-efficacy and physical activity 
(Australian Government, 2005). Self-management and self-management support are key 
aspects of optimal chronic disease care based on research in self-care programs (Glasgow, 
Jeon, Kraus, & Pearce-Brown, 2008).  
 
This study showed that small equipment implementation can make a significant difference in 
feelings of comfort and self-management. For example, the use of a handheld fan was praised 
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in this study and reinforced in a randomized controlled crossover trial (Galbraith et al., 2010). 
Use of this inexpensive, non-invasive and patient-directed device, pointed at the face, reduces 
the sensation of breathlessness and is recommended in palliative care management (Galbraith 
et al., 2010). One study was unable to conclusively prove the benefit of a handheld fan 
(Bausewein, Booth, Gysels, Kühnbach, & Higginson, 2010). However, given that an 
intervention like this might reduce individual’s experience of breathlessness and has no ill 
effects, it should be considered given the distress patients suffer and the positive reports, 
including from participants in this study. 
 
The seriousness of each person’s reported experience supports the argument that further 
research is needed to reduce what Chin, & Booth (2016) call the unnecessary suffering that 
refractory breathlessness brings when it is inadequately managed. They point to the potentials 
of a genuinely multi-disciplinary approach to evaluate both the science and the delivery of 
services to sufferers, including a deeper understanding of the meaning of breathlessness for 
those living with it.   
 
Studies suggest that the most effective treatment path for refractory breathlessness is a 
combination of pharmacological and non-pharmacological approaches (Bausewein, Jolley, 
Reilly, Lobo, Kelly, Bellas, Madan, Panell, Brink, De Biase, Gao, Murphy, McCrone, 
Moxham, et al., 2012; Chin & Booth, 2016; S. Simon & Bausewein, 2009). Progress has been 
made in identifying the links between pathophysiology and the origin of breathlessness, as 
well as pharmacological treatment – particularly opioids and non-pharmacological 
interventions (Davidson & Currow, 2010; Johnson, Abernethy, & Currow, 2012). 
 
56	
 
An occupational therapy perspective brings an opportunity to support this group with better 
self-management, intervention and coping strategies. It takes into account individual 
circumstances and needs so each patient may be less fearful and better supported to 
experience the best quality of life accessible to them at their stage of illness (Morgan & 
White, 2012). 
 
Given its prevalence and the severity of symptoms, refractory breathlessness is deserving of 
ongoing research in all aspects (Davidson & Currow, 2010). Adequate and individualised 
understanding and support are called for. Building on the non-pharmacological contributions 
to more effective patient support, occupational therapy research in palliative care already 
shows that through functional participation in everyday activities (such as those discussed in 
this study), individuals can more effectively maintain a sense of self and control over their 
changing physical self (Davidson & Currow, 2010; Mattingly & Fleming, 1994; Morgan & 
White, 2012). 
 
Limitations of this study included the small study size and all study participants coming from 
the Sydney metropolitan area. The small study size was anticipated by the distressing nature 
of the illness and disease progression and sourcing participants from a single Sydney clinic, 
influencing their experience of their illness. Importantly however, data saturation was reached 
in this study even with a relatively small sample size. Interviewees repeated consistent 
themes, particularly around self-management behaviours for their breathlessness and how this 
symptom limits their lives. A larger sample with multi-centre recruitment could enable a more 
comprehensive analysis. The non-responders in this study may have been individuals whose 
physical or psychological distress or illness progression made them unable to participate, 
which may mean that the findings from this study have under-estimated the distress 
experienced by participants.   
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Conclusion  
 
This study identified four key themes, two of which, namely Reduced to the Basics and 
Sources of Security may be particularly well suited towards occupational therapy 
interventions. Participants noted the importance of functional participation for improved 
engagement and quality of life for individuals suffering from refractory breathlessness. Our 
literature review research found limited studies regarding specific interventions for self 
management and for equipment prescription, supporting the need for further research.  
 
Key Points for Occupational Therapy 
 
- The functional and psychological consequences of refractory breathlessness impair 
individuals’ quality of life and activities of daily living. 
- Occupational therapists have a role in improving individuals’ experience with 
refractory breathlessness, through equipment prescription and teaching of self-
management techniques. 
- A handheld fan can empower and promote self-efficacy for patients.	 	
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Table 1: Demographic characteristics of participants (n=6) 
 
 Sex Age Marital status Aetiology 
Participant 1 (P1) M 86 De facto COPD 
Participant 2 (P2) F 63 Married COPD 
Participant 3 (P3) F 71 Single Lung Cancer 
Participant 4 (P4) M 69 Married Heart Failure 
Participant 5 (P5) F 67 Married COPD 
Participant 6 (P6) F 54 Single Metastatic Breast Cancer 
 
 
 
 
Table 2: Themes and sub themes  
 
Main 
Themes 
Subthemes 
Living on 
the edge 
Reality of 
breathlessness 
Experiences 
of not being 
able to 
breathe 
Adapting to 
breathlessness 
Frustration 
with 
breathlessness 
 
Social 
Needs and 
Support 
Social support 
is vital 
Pragmatics 
of getting 
out and 
about 
Effect of 
breathlessness 
on 
relationships 
with others 
  
Reduced 
to the 
Basics 
Adjusted 
capabilities 
Capacity to 
undertake 
Activities of 
Daily Living 
(ADLs) 
Psychological 
distress 
 
Sleep and rest Pacing 
Sources of 
security 
Hand held fan Equipment 
to help with 
coping 
Feelings of 
security  
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Ethical approval letter - HammondCare Greenwich Hospital Research 
Governance Body 
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Interview schedule 
 
Interview questions for qualitative study of the experience of breathlessness in everyday 
life  
Interview conducted by Kezia Tieck at Greenwich Hospital  
Introduce herself explain purpose of interview and confirm consent.  
I understand it may be an effort for you to speak with me today due to your breathlessness so 
we can go as slowly as you wish, take breaks, and stop whenever you’ve had enough.  
 
Can you tell me a bit about yourself and how you came to be at the clinic?  
  -  Age   
  -  Social support   
  -  Where you live, whether your house or apartment is easy for you to manage, if you 
have some regular help at home?   
  -  Working?   
  -  Previously working if unable now?   
  -  Other medical problems affecting their health and breathlessness?  
 
How have you come to have this degree of breathlessness?   
  -  Underlying condition?   
  -  And how long has breathlessness been a daily challenge for you?   
  -  How is it today?   
 
What does your breathlessness feel like to you?   
  -  Breathing is rapid?  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  -  Breath does not go all the way in /out?   
  -  Shallow breathing?   
  -  Breathing requires more effort?   
  -  Chest feels tight?   
  -  Cannot get enough air?   
  -  Feeling out of breath?   
 
Generally, how would you say your breathlessness affects your life?   
  -  Effect on mood? Energy?   
  -  Pain?   
  -  Tiredness?   
  -  Frustration?   
 
What does a typical day look like for you?   
- Think about ADLS that the patient mentions they can or can’t do.  
 
What sort of activities are an issue for you in the morning afternoon and evening?  
  -  Showering   
  -  Dressing   
  -  Personal care   
  -  Home duties   
  -  Getting out of the house   
  -  Driving   
  -  Medical appointments  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  -  Social contacts   
  -  Community activities   
 
How does breathlessness affect your rest and sleep? Do you feel like you have a restful 
night?  
  -  Sleeping struggles   
  -  Sleeping comfortably   
  -  Sleeping position (propped up or flat)   
  -  Can you sleep lying down?   
  -  Open prompt – to discuss any sexual activities issue due to breathlessness if it 
 arises.  
 
Is there an activity you really long to do or particularly miss doing?   
  -  Previous activity capability vs current capabilities.   
  -  Can you imagine how this might be possible? Or is it not possible anymore?   
 
What sort of support do you have or feel you need?   
  -  Partner?   
  -  Carer?   
  -  Family?   
  -  Friend?   
  -  No support?   
  -  Is this care helpful?   
  -  How does the support help you?   
 
78	
 
Do you have any spiritual support that you rely on for guidance or direction?   
          - Faith - Influence   
How has your breathlessness affected your relationships with your partner, friends 
and/or family?   
  -  Personal relationships?   
  -  Social relationships/activities   
  -  Feeling like a burden   
  -  Limiting participation for activities   
 
Do you feel that the people around you understand how breathlessness affects you?   
- What would help them to understand better?  
 
Is there some small discovery that you’ve made about living with breathlessness that 
you’d like to share, or that we could share with other people?  
  -  Coping technique   
  -  Outlook   
  -  Management strategy   
  -  Care that’s been helpful   
  -  Support network  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Literature search strategy 
 
 
Search strategy example. Search terminology applied for Medline.  
 
1. Dyspnea/ 
 
2. (short* adj3 breath*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
3. breathless*.mp. 
 
4. (difficult* adj2 breath*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
5. 1 or 2 or 3 or 4 
 
6. Chronic Disease/ 
 
7. (chronic* or refractor* or persistant*).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, synonyms] 
 
8. severe.mp. 
 
9. ((end or late) adj2 stage*).mp. [mp=title, abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
10. 6 or 7 or 8 or 9 
 
11. 5 and 10 
 
12. Self Report/ 
 
13. (patient* adj2 experienc*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms] 
 
14. 12 or 13 
 
15. 11 and 14 
 
16. exp "Activities of Daily Living"/ 
 
17. 11 and 16 
 
18. 15 or 17  
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ICF framework in context of refractory breathlessness patients  
 
The following domains have been set out by the World Health Organisation for the use in 
applying the ICF model. The table below displays the model clearly by section. 
 
Reflecting the relevance of this model for the patient group of this study, highlighted items 
are areas that could potentially be relevant to someone in this population. 
 
Body Function 
• Mental Functions  
• Sensory Functions and Pain  
• Voice and Speech Functions  
• Functions of the Cardiovascular, 
Haematological, Immunological and 
Respiratory Systems  
• Functions of the Digestive, Metabolic, 
Endocrine Systems  
• Genitourinary and Reproductive Functions  
• Neuromusculoskeletal and Movement-
Related Functions 
• Functions of the Skin and Related 
Structures  
 
Body Structure 
• Structure of the Nervous System  
• The Eye, Ear and Related Structures  
• Structures Involved in Voice and Speech  
• Structure of the Cardiovascular, 
Immunological and Respiratory Systems  
• Structures Related to the Digestive, 
Metabolic and Endocrine Systems  
• Structure Related to Genitourinary and 
Reproductive Systems  
• Structure Related to Movement  
• Skin and Related Structures  
 
Activities and Participation  Environmental Factors  
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• Learning and Applying Knowledge  
• General Tasks and Demands  
• Communication  
• Mobility  
• Self Care  
• Domestic Life  
• Interpersonal Interactions and 
Relationships  
• Major Life Areas 
• Commmunity, Social and Civic Life  
 
• Products and Technology  
• Natural Environment and Human-Made 
Changes to Environment  
• Support and Relationships  
• Attitudes  
• Services, Systems and Policies  
 
 
It is clear all areas potentially could have factors influencing the patient group, particularly 
activities and participation which is disrupted in a significant way by the underlying health 
condition. 
 
An example of how the disabilities associated with refractory breathlessness may be linked 
with the three levels of functioning specified in this model, and tied back to the health 
condition below. This is an example only but could be utilised for each patient interviewed. 
 
Health Condition Impairment Activity Limitation Participation 
Restriction 
Refractory 
Breathlessness 
Impaired respiratory 
function 
Difficulty engaging 
in social situations 
as it is too tiring 
Limited social 
participation leads to 
isolation and few 
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going out to meet 
friends or family. 
social relationships.  
 
The next chart shows how the different levels of disability are linked to the levels of 
intervention and prevention. 
 
 Intervention Prevention 
Health Condition • Medical treatment 
• Medications  
• Breathing aids such as oxygen 
• Breathlessness Clinic 
• Nutrition  
• Immunisations to prevent 
flu seasonally. 
• Staying as physically well 
as possible. 
Impairment • Medical treatment 
• Medications  
• Breathing aids such as oxygen 
• Breathlessness Clinic 
• Not preventable but can be 
managed effectively as 
possible. 
Activity Limitation • Assistive devices 
• Family support 
• Breathlessness Clinic support 
 
• Rehabilitation to try and 
slow progression of 
refractory breathlessness. 
• Try and prevent isolation 
but some sort of activity 
engagement in a meaningful 
setting. 
Participation 
Restriction 
• Assistive devices such as 
motorised scooters to mobilise. 
• Universal accessible design 
• Environmental changes  
• Universal design 
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Australian Occupational Therapy Journal Author Guidelines 
Australian Occupational Therapy Journal Requirements 
 
CONTENTS 
1. SUBMITTING TO AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL 
2. EDITORIAL CONSIDERATIONS 
3. ETHICAL CONSIDERATIONS 
4. ARTICLE TYPES AND REQUIREMENTS 
5. PREPARING THE MANUSCRIPT 
6. COPYRIGHT, LICENSING AND ONLINE OPEN 
7. PUBLICATION PROCESS AFTER ACCEPTANCE 
8. POST PUBLICATION 
9. EDITORIAL OFFICE CONTACT DETAILS 
1. SUBMITTING TO AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL 
Thank you for your interest in Australian Occupational Therapy Journal. Submissions are 
only received through the “Scholar One” manuscript central website accessed through the 
journal home page. 
Authors should register at https://mc.manuscriptcentral.com/aotj and follow online 
submission instructions. Manuscripts that fail to meet requirements of the Author Guidelines 
will be rejected without review. 
For help with submissions, please contact the Editorial Assistant: aot.eo@wiley.com 
Australian Occupational Therapy Journal Article Submission “Checklist for Authors” 
The following checklist will appear as part of the online submission process. Authors must 
confirm adherence to all items. 
I have adhered to all of the following in the manuscript submitted 
• The manuscript was double-spaced in 12 point Times New Roman or Times Roman font 
and does not exceed the permitted word count. 
• I used Australian-English spelling. 
• The abbreviation of ”OT” or “OTs” was not used. 
• The submitted manuscript did not contain any identifying information about specific people, 
programs, locations or study sites. 
• I consulted the Publication Manual of the American Psychological Association, Sixth 
Edition and/or the official companion APA Style Blog (http://blog.apastyle.org/apastyle/) to 
prepare correct citations and references. All journal articles published after 1997 included the 
digital object identifier (doi) presented according to APA style rules. 
• The corresponding author obtained and included his/her ORCID number. 
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• The “Abstract” was no longer than 300 words and used the following headings: 
Introduction; Methods; Results; Conclusion. 
• Abbreviations followed the Publication Manual of the American Psychological Association, 
Sixth Edition /or the official companion APA Style Blog (http://blog.apastyle.org/apastyle/); 
this included abbreviations in the reference list. 
• Up to five keywords were selected from either the U.S National Library of Medicine Medical 
Subject Headings (MeSH) (https://www.nlm.nih.gov/mesh/) or the Cumulative Index to 
Nursing and Allied Health Literature Thesaurus. Only MeSH or CINAHL words were used. 
• The Main Document used subheadings set out in the Guidelines. 
• If my study used humans, I provided details of the Institutional Review Board, Human 
Research Ethics Committee or equivalent delegated authority in the Scholar One form where 
indicated and these details were also written into the Method Section of the manuscript 
(blinded for review) 
• Research articles followed the reporting guidelines presented in http://www.equator-
network.org/. I note reviewers will be asked to evaluate the manuscript in light of these 
guidelines. I provided evidence of adherence as a supplementary document: e.g., 
prospective clinical trial registration. 
• A section called “Key Points for Occupational Therapy” was included at the end of the 
paper, before “references”. 
• A section called “Declaration of Authorship” was included after “Key Points” and before 
“references”. The declaration stated the contribution of each author to the paper and any 
conflict of interest. I/we used wording that demonstrated adherence to the roles and 
responsibilities of authors described in the International Committee of Medical Journal 
Editors (ICMJE) recommendations (http://www.icmje.org/). 
• A section called “Funding” was included after the author declaration. 
• People or institutions who were acknowledged gave written permission. 
2. EDITORIAL CONSIDERATIONS 
Aims and Scope 
The Australian Occupational Therapy Journal is a leading international peer reviewed 
publication presenting influential, high quality innovative scholarship and research relevant to 
occupational therapy. 
The journal is the official research publication of the professional peak body, Occupational 
Therapy Australia. The journal publishes empirical studies, theoretical papers, reviews and 
invited scholarly commentary. 
The aim of the journal is to be a leader in the dissemination of scholarship and evidence to 
substantiate, influence and shape policy and occupational therapy practice locally and 
globally. 
Preference will be given to papers that have a sound theoretical basis, methodological rigour 
with sufficient scope and scale to make important new contributions to the occupational 
therapy body of knowledge. 
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Topics may include: 
- how participation in occupation is affected by body structures and function domains 
- participation in occupations across the lifespan 
- environments affecting engagement in occupation and occupational therapy services 
(physical, social, policy etc.) 
- interaction of person, environment and occupation factors to influence health 
- people who receive, could receive or who are impacted by occupational therapy practice, 
policy or education; 
- assessments measuring constructs relevant to and applied in occupational therapy 
research, practice or education; 
- occupational therapy interventions (development, implementation and impact) 
- scope of occupational therapy practice 
- professionalisation and professionalism in occupational therapy 
- pedagogy and educational practice involving occupational therapy, including 
interprofessional , multidisciplinary, transdisciplinary and single discipline research that 
includes occupational therapy and/or occupational therapy students/ staff. 
Authors must position their study in an appropriate and sound theoretical and empirical 
context; with a critical analysis of relevant literature in the Introduction section. The 
manuscript must demonstrate how findings make an important contribution to knowledge in 
the field. 
For quantitative papers, authors are encouraged to demonstrate how their studies enable 
replication, generalizability and contribute to understanding possible or actual causality. 
Typically this will involve reporting using guidelines such as those available in the EQUATOR 
network. Authors must use measures that are well validated and have proven psychometric 
properties. 
Authors are encouraged to triangulate data to substantiate their findings where appropriate, 
for example: self-report measures and performance observation measures; therapist and 
consumer measures/ perspectives. 
The journal preferences qualitative research that contributes to development of substantive 
or formal theory, is empirically grounded, is internally reflexive and has explored its value for 
different groups including study participants. Studies that demonstrably illuminate aspects of 
occupational therapy and can thus inform decision making will be of particular interest to 
readers. Qualitative studies must demonstrate transferability, dependability, trustworthiness, 
and credibility. 
86	
 
In mixed method research, authors are required to clearly outline how the a-priori design 
demonstrates integration of qualitative and quantitative methods during data collection, 
analysis and reporting. When a mixed method approach is reported, authors should clearly 
identify the design (e.g., sequential explanatory, sequential exploratory, concurrent nested, 
etc.) and report which data took priority during data collection and analysis (e.g., did 
qualitative data lead the results with support from the quantitative?). Consideration should be 
given to whether the approach used is mixed or multiple methods. 
Instrumentation studies present the development and/or evaluation of the psychometric 
properties of a tool – reliability, validity, sensitivity, clinical utility. The journal has a 
preference for standardised taxonomies such as COSMIN. 
The Australian Occupational Therapy Journal receives many more papers than it can 
publish. Studies may be methodologically appropriate, have significant or original results, but 
that may not mean the paper is a significant contribution to new knowledge. The journal aims 
to publish research that will provide a rigorous, relevant evidence base to inform professional 
practice and decisions relating to occupational therapy. Authors must demonstrate that their 
research is thus not only technically competent but is an original and significant contribution 
to knowledge and practice. 
The journal will consider multidisciplinary or interprofessional studies that include 
occupational therapy, occupational therapists or occupational therapy students, so long as 
‘key points’ highlight the specific implications for occupational therapy, occupational 
therapists and/or occupational therapy students and/or consumers. 
If authors extract material from single larger interprofessional or multidisciplinary studies for 
an occupational therapy-specific study, these papers are only acceptable if distinct and 
separate questions are asked, if a theoretically and empirically grounded rationale is 
provided for the extracted study, and if the methodology is appropriate to the question 
If authors are submitting a paper where data is derived from a larger study, authors are 
required to disclose all related publications that are published, submitted or under review. If 
authors state that aspects of the study have already been published, a case must be made to 
demonstrate how the present paper is distinctive and makes a significant contribution to 
knowledge. 
Conditions of submission 
Papers submitted to the journal must not be presenting content that has been previously 
published. The only exceptions to this rule are the following: conference abstracts; part of a 
published lecture or academic thesis; as an electronic preprint; poster/ abstract/ oral 
presentation presented at a conference or scientific meeting where proceedings are available 
on a pre-print server. 
Papers that present clinical trials are not deemed to have been previously published if they 
appear in clinical trials registers and/or if results in such registers are presented as a brief 
summary or table. 
Papers submitted to the journal must not be under consideration for publication elsewhere. 
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If accepted for publication, authors agree the paper will not be published elsewhere in the 
same form, in English or in any other language, including electronically without the written 
consent of the copyright-holder which is the journal publisher. Authors must be aware that in 
signing the copyright form they are entering a legal agreement not to disseminate or 
republish the journal-article on any file sharing site, by email attachment, in thesis 
dissertations or in any other form. Authors are able to disseminate the pre-production 
manuscript if they own the copyright and they are able to include citation details of the 
Australian Occupational Therapy Journal published paper on such documents. 
All papers submitted to the Australian Occupational Therapy Journal are subject to 
automated text-matching software screening which reports a % similarity index. 
Editorial Processes 
All submissions are inspected by the Editorial Team first to determine whether all criteria in 
the “Checklist for Authors” have been met. A paper that does not meet criteria will be 
rejected and returned to authors. 
Second, Editorial inspection determines whether or not papers are within the journal “Aims 
and Scope”. The Editorial Board may decide to reject any paper not deemed to be within the 
Aims and Scope of the journal. A reason for rejection will be provided. The decision is final. 
A paper deemed to be in line with the “Aims and Scope” of the Journal will be blind-reviewed 
by one member of the Editorial or Review Board and either a specialist guest-reviewer or 
another member of the Editorial or Review Board. Reviewers will provide feedback using 
the Australian Occupational Therapy Journal review-form. Reviewers will be directed to 
consider the methodological quality of the study and may choose to use standardised critical 
appraisal tools. Reviewers will provide blind comment to authors regarding the manuscript. 
Reviewers will make confidential recommendations to the Editorial Board regarding 
publication priority. The Editorial Board will use reviewer reports to inform decisions 
regarding acceptance, rejection, or provision of opportunities to revise and resubmit. 
Resubmissions have no guarantee they will be accepted. A rejection decision is final; no 
further correspondence will be entered into. 
An accepted paper is submitted to the WILEY production process. 
Authors will receive the page-proofs for their paper and are required to review for accuracy; 
any changes beyond accuracy may incur a charge. The author-approved proof is sent to the 
Editor in Chief for final review. The Editor and the Publisher reserve the right to make minor 
modifications to typescripts to correct spelling or grammar issues that have been overlooked, 
or eliminate ambiguity and repetition. A paper is not approved for publication, regardless of 
the stage of review or correspondence sent and received until the Editor in Chief approves 
publication of the final proof. If an author identifies an error after publication that is their 
responsibility, he/she/they are responsible for costs associated with correction and 
publication of corregium. 
3. ETHICAL CONSIDERATIONS 
This journal is a member of the Committee on Publication Ethics (COPE). 
Human Studies 
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For manuscripts reporting studies involving human participants or data originally generated 
from human participants (e.g., chart reviews, program evaluations, secondary data 
analyses), we require a statement identifying how ethical and /or research governance 
approval was obtained, where and under what authority it was granted. Authors must provide 
the name of the committee and state the reference number where appropriate. The name of 
the approving committee/s should be included in the manuscript (but de-identified for blind 
review purposes) – it is not acceptable to refer to “researcher institutional ethics committees” 
in general. 
For research conducted in Australia or through Australian institutions the National Statement 
on Ethical Conduct in Human Research 2007 - updated May 2015 applies 
(https://www.nhmrc.gov.au/guidelines-publications/e72).; for research with Indigenous 
Australians this also includes the companion document “Values and Ethics - Guidelines for 
Ethical Conduct in Aboriginal and Torres Strait Islander Health Research” (NHMRC, 2003). 
For research conducted by investigators in countries other than Australia, there is a 
requirement for authors to demonstrate that the research complied with principles of the 
World Medical Association Declaration of Helsinki Ethical Principles for Medical Research 
involving Human Subjects as amended October 2000 and that research was conducted with 
institutional or equivalent approvals consistent with the World Health Organization 
“Standards and operational guidance for ethics review of health-related research with human 
participants” (2011). Failure to provide this information or demonstrate this requirement will 
result in the submission being rejected. 
Clinical Trial Registration 
Clinical trials will normally be prospectively registered in a publicly accessible database and 
clinical trial registration numbers should be included in all papers that report results. Include 
the name of the trial register and your clinical trial registration number at the end of your 
abstract. 
If your trial is not registered, or was registered retrospectively, please explain the reasons for 
this in the cover letter. 
Research Reporting Guidelines 
Accurate and complete reporting enables readers to fully appraise research, replicate it, and 
use it. The Australian Occupational Therapy Journal will publish positive, negative and 
inconclusive results as long as the research is rigorous. 
Authors must adhere to research reporting standards presented in the EQUATOR network 
(http://www.equator-network.org/). 
Authors must submit the relevant EQUATOR reporting guideline checklist as a not-to-be-
published supplementary document to the submission. If authors do not believe one of these 
guidelines is appropriate a rationale must be provided in the cover letter and an alternative 
standards benchmark provided. 
Roles and Responsibilities of Authors 
An author is someone who demonstrates roles and responsibilities defined by the 
International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/). A 
declaration must be made to this effect. 
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The ICMJE recommends that authorship be based on the following criteria: (i) Substantial 
contributions to the conception or design of the work; or the acquisition, analysis, or 
interpretation of data for the work; ( ii) Drafting the work or revising it critically for important 
intellectual content; (iii) Final approval of the version to be published; and ( iv) Agreement to 
be accountable for all aspects of the work in ensuring that questions related to the accuracy 
or integrity of any part of the work are appropriately investigated and resolved. 
Conflict of Interest 
Authors should disclose any actual or perceived conflicts of interest. Any interest or 
relationship, financial or otherwise that might be perceived as influencing an author's 
objectivity is considered a potential source of conflict of interest. These must be disclosed 
when directly relevant or directly related to the work that the authors describe in their 
manuscript. Potential sources of conflict of interest include, but are not limited to, patent or 
stock ownership, membership of a company board of directors, membership of an advisory 
board or committee for a company, and consultancy for or receipt of speaker's fees from a 
company. The existence of a conflict of interest does not preclude publication. If the authors 
have no conflict of interest to declare, they must also state this at submission. It is the 
responsibility of the corresponding author to review this policy with all authors and 
collectively to disclose with the submission ALL pertinent commercial and other relationships. 
Funding 
Authors must make a funding statement. This will appear at the end of the paper before the 
reference section. Authors should list all funding sources. All funding received for work 
described within a submitted manuscript must be acknowledged in the funding disclosure 
section. Provide the name of the funder, the grant number, and the name of the principal 
investigator as applicable. If there was no specific study funding, then the authors should 
report the following statement: “This research received no specific grant from any funding 
agency in the public, commercial, or not-for-profit sectors.” 
Acknowledgements 
The contribution of colleagues or institutions can be acknowledged. Personal thanks and 
thanks to anonymous reviewers are not appropriate. Acknowledgements should contain 
information on individuals who have contributed to this work but did not meet the criteria for 
authorship or decline to be included as an author. All those individuals who are named in the 
acknowledgements must be contacted by the author and agree to have their name included. 
Each individual’s specific contribution to the work must be briefly stated. Acknowledgements 
of general support or mentorship will be deleted by the editor as acknowledgements are only 
for those individuals who have provided a specific contribution to this work. In addition, the 
authors must provide information on previous dissemination of this work, in part or whole, at 
conferences or workshops. Prior presentation of the paper at a meeting should be briefly 
described last. 
4. ARTICLE TYPES AND REQUIREMENTS 
Type	of	Article	 Word	limit	
(excluding	
abstract,	
references,	
tables	and	
Abstract	
required	-	
word	limit	
Number	of	
references	
allowable	
No.	of	tables	or	
figure	files	
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figures	
Feature	
5000	 300	 35	 4	
 	
Review	*	
5000	 300	 35	 4#	
 	
Viewpoints	(invited	
only)	 2000	 150	 15	 2	
 	
Critically	Appraised	
Papers	 800	 NA	 10	 0	
 	
Letter	to	Editor	
300	 NA	 3	 0	
 	
* Refer to full detail regarding length, references and tables for Review Articles below 
# Usually published in online-only format 
All articles 
All articles must be accompanied by a cover letter that addresses how the paper complies 
with conditions of submission. 
If content is derived from a larger study, study series or previously published work, the 
authors must explain in the cover letter how their submission makes an original and 
substantial contribution to new knowledge and they must include citations and doi links for all 
related/ derivative studies. 
The cover letter should include a statement regarding written permissions for photographs, 
personal communications, and copyrighted material. These written permissions should be 
attached to the cover letter. 
The cover letter should confirm that any person or institution named in the 
acknowledgements has given permission 
Feature Articles 
Feature Articles can be in the form of research papers, theoretical papers, case reports or 
descriptive articles. Manuscripts should not exceed 5000 words including Key Points, Author 
Declaration and conflict of interest, funding and acknowledgement. The Title, Abstract and 
References are not included in the word count. 
Feature articles should contain the following: 
Title page: This will be a separate file to the main document – upload using the “title page” 
option in Scholar One. The title page should contain: 
(i) a short informative title that contains the major content concepts. The title should not 
contain abbreviations (see our best practice SEO tips); 
(ii) the full names, qualifications and designations of the authors; 
(iii) the full addresses of the authors’ affiliations; 
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(iv) a short running title (no more than 40 characters, abbreviations are permitted); 
(v) authors’ declaration of authorship contribution*; 
(vi) funding statement*; 
(vii) conflict of interest statement*; 
(viii) acknowledgements*; 
(ix) word length for the main text excluding references, abstract and tables; 
(x) word length of the abstract; 
(xi) the number of references, figures and tables include as part of article; 
(xii) Designate the corresponding author by providing his or her full address, telephone and 
fax numbers, and e-mail address. 
(xiii) A minimum of five MeSH or CINAHL terms should be included as key words 
*In the printed publication these will appear at the end of the paper before “references” – they 
are included here in the title page because this is not sent out to reviewers. 
Structured abstract: 300 word limit including Introduction, methods, results and conclusion. 
Introduction: The aims of the article should be clearly stated and a theoretical framework (if 
applicable) should be presented with reference to established theoretical model(s) and 
background literature. A succinct review of current literature should set the work in context. 
The introduction should not contain findings or conclusions. The aim of the research should 
be stated at the end of the introduction section. 
Methods: This should provide a description of the method (including recruitment of subjects, 
study procedures, instruments and data analysis) in sufficient detail to allow the work to be 
repeated by others. Name (but de-identify for review) the Human research Ethics 
Committee/s or equivalent if human participants were involved. 
Results: Results should be presented in a logical sequence in the text, tables and figures. 
Participant characteristics are presented in results. The same data should not be presented 
repetitively in different forms. 
Discussion: The discussion should consider the results in relation to the study purpose, 
practice and scholarly context. The relationship of your results to the work of others and 
relevant methodological points could also be discussed. Limitations of the study should be 
identified. Implications for practice and future research should be considered. A conclusion 
section may be used but is not mandatory. 
Key Points for Occupational Therapy: This is included at the end of the paper, before 
“references”. It comprises a bulleted list of three points summarising implications of the paper 
for occupational therapy practice/ policy or and or education. These should not exceed 45 
words in total (that is, 10-15 words each). Each point should reflect the journal's aim and 
scope above and must not simply restate the findings. 
References: No more than 35 references. 
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Standard inclusions of Author Declaration including conflict of interest, funding statement, 
acknowledgement if appropriate: This will be a separate file to the Main Document – upload 
as “supplementary file” not for review. Normally no more than 100 words. 
Tables and/or Figures: No more than 4 will be included. Large Tables or Figures may be 
published as on-line only files to permit efficient production of the print-version of the journal. 
The file link will be published in the print version. 
Appendices are not permitted. 
(Reporting Guidelines will normally be included as a non-published supplementary file in the 
submission. In some cases, e.g., CONSORT flow-chart, aspects of the guidelines may be 
included in the main document) 
Reviews 
Narrative reviews, scoping reviews, meta-syntheses, systematic reviews and meta-analyses 
are included in this category. 
Review articles should contain the following: 
Title page: This will be a separate file to the main document – upload using the “title page” 
option in Scholar One. The title page should contain: 
(i) a short informative title that contains the major content concepts. The title should not 
contain abbreviations (see our best practice SEO tips); 
(ii) the full names, qualifications and designations of the authors; 
(iii) the full addresses of the authors’ affiliations; 
(iv) a short running title (no more than 40 characters, abbreviations are permitted); 
(v) authors’ declaration of authorship contribution*; 
(vi) funding statement*; 
(vii) conflict of interest statement*; 
(viii) acknowledgements*; 
(ix) word length for the main text excluding references, abstract and tables; 
(x) word length of the abstract; 
(xi) the number of references, figures and tables include as part of article; 
(xii) Designate the corresponding author by providing his or her full address, telephone and 
fax numbers, and e-mail address. 
(xiii) A minimum of five MeSH or CINAHL terms should be included as key words; Note that 
MeSH key words are reviewed by an indexer and may be edited. 
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*In the printed publication these will appear at the end of the paper before “references” – they 
are included here in the title page because this is not sent out to reviewers. 
Structured abstract: No more than 300 words including Introduction, methods, results and 
conclusion. 
Introduction: A rationale and context for the review must be provided. The aim of the review 
should be stated at the end of the introduction section. 
Methods: The methodology used to design and conduct the review should be presented in 
sufficient detail to allow the work to be repeated by others. 
Results: Results should be presented in a logical sequence in the text, tables and figures. 
Details of sources retrieved and analysis findings are presented in results. The same data 
should not be presented repetitively in different forms. 
Discussion: The discussion should consider the results in relation to the study purpose, 
practice and scholarly context. The relationship of your results to the work of others and 
relevant methodological points could also be discussed. . Limitations of the review should be 
identified. Implications for practice and future research should be considered. A conclusion 
section may be used but is not mandatory. 
Key Points for Occupational Therapy: This is included at the end of the paper, before 
“references”. It comprises a bulleted list of three points summarising implications of the paper 
for occupational therapy practice/ policy or and or education. These should not exceed 45 
words in total (that is, 10-15 words each). Each point should reflect the journal's aim and 
scope above and must not simply restate the findings. 
References: Review articles use references as part of the introduction, method and in the 
discussion to frame the study. They also present references as ‘data’ or findings. Authors 
should consider these two reference types when preparing the manuscript. Up to 20 “usual” 
main document references may be used (i.e., sources cited in the introduction, method and 
discussion to place the review findings in context). There is no limit on the number of 
‘references’ reported in the research results. Typically author, title, source details will be 
presented in ‘results tables’, but the full citation with doi will appear in the reference list along 
with “usual” references. 
Standard inclusions of Author Declaration including conflict of interest, funding statement, 
acknowledgement if appropriate: This will be a separate file to the Main Document – upload 
as “supplementary file” not for review. Normally this will be no more than 100 words. 
Tables and/or Figures: No more than 4 will be included. Large Tables or Figures may be 
published as on-line only files to permit efficient production of the print-version of the journal. 
The file link will be published in the print version. 
Appendices are not permitted. 
(Reporting Guidelines will normally be included as a non-published supplementary file in the 
submission) 
Viewpoints 
Viewpoints are Invitation only papers. Viewpoints provide a forum for the debate and 
discussion of pertinent occupational therapy issues and related concerns. Authors are 
encouraged to discuss topical and controversial issues, and to do so in a manner that sheds 
light on or challenges established practices and beliefs. In many cases, discussion will 
require attention to varying opinions. A viewpoint may be an appropriate avenue for readers 
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to debate the content of previous Viewpoints or other articles that have appeared in the 
journal. Proposals for Viewpoint articles can be made to the Editorial Board via the Editorial 
Office (aot.eo@wiley.com); provide a rationale, brief outline of the topic and the position to 
be taken. 
Viewpoints should contain the following: 
Title Page: 
Abstract: No more than 150 words 
Main document: No more than 2000 words, 
References: No more than 15 references. 
Author declaration including conflict of interest: This should be supplied, to be published at 
the discretion of the Editorial Board 
Critically Appraised Papers 
Critically Appraised Papers are solicited by the Editorial Office. If you would like to propose 
an idea for a CAP, please contact the Editorial Office (aot.eo@wiley.com) with a brief outline 
of the topic. 
Letters to the Editor 
Letters to the Editor will only be published online. 
Main Document: No more than 300 words 
References: No more than 3 references using APA format including doi numbers. 
Author declaration including conflict of interest: This should be supplied, to be published at 
the discretion of the Editorial Board 
5. PREPARING THE MANUSCRIPT 
Writing for Search Engine Optimization 
Optimize the search engine results for your paper, so people can find, read and ultimately 
cite your work. Simply read our best practice SEO tips – including information on making 
your title and abstract SEO-friendly, and choosing appropriate MESH keywords. 
http://www.wiley.com/legacy/wileyblackwell/pdf/SEOforAuthorsLINKSrev.pdf 
Spelling. The journal uses Australian spelling and authors should therefore follow the latest 
edition of the Macquarie Dictionary. Note spelling of the following commonly used words 
spelled based on Australian standards: centre, standardise, hospitalise, analyse, civilise, 
ageing, colour, honour, program, paediatrician, install. Please note the difference between 
practice as a noun and practise as a verb. 
APA Style. Manuscripts should follow the style of the American Psychological Association 
(6th edition), except in regards to spelling. The APA website includes a range of resources 
for authors learning to write in APA style, including An overview of the Publication Manual of 
the American Psychological Association, Sixth Edition ; free tutorials on APA Style 
basics and an APA Style Blog. Please note APA referencing style requires that a DOI be 
provided for all references where available. 
Footnotes and Endnotes are not to be used. 
Terminology. Choice of terminology used to describe a person with an impairment or 
disorder should reflect respect (e.g., do not use 'an autistic', 'the epileptics', ‘the mentally 
retarded’), should protect dignity (e.g., do not use 'suffering', 'case'), and should be free of 
stereotypes (e.g., do not use 'confined to a wheelchair', 'victim'). 
Units. All measurements must be given in the International System of Units (SI) or SI-
derived units, being the modern form of the metric system. 
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Statistics. Exact p values should be given to no more than three decimal places. Wherever 
possible give both point estimates and confidence intervals for all population parameters 
estimated by the study (e.g. group differences, frequency of characteristics). Identify the 
statistical package used. Identify the statistical package used. 
Abbreviations. Abbreviations should be used sparingly - only where they ease the reader's 
task by reducing repetition of long, technical terms. Initially use the word in full, followed by 
the abbreviation in parentheses. Thereafter use the abbreviation only. Do not use 
abbreviations in the title or abstract of the article. The abbreviation of OT referring to 
occupational therapist or occupational therapy is not acceptable in the manuscript. Use 
occupational therapist or occupational therapy, as appropriate. 
Supporting Information Supporting information is not essential to the article but provides 
greater depth and background and may include tables, figures, videos, datasets, etc. This 
material can be submitted with your manuscript, and will appear online, without editing or 
typesetting. Guidelines on how to prepare this material and which formats and files sizes are 
acceptable can be found at: http://authorservices.wiley.com/bauthor/suppmat.asp Please 
note that the provision of supporting information is not encouraged as a general rule. It will 
be assessed critically by reviewers and editors and will only be accepted if it is essential. 
File Upload 
Scholar One will cue authors to input information and upload files in a particular order. Some 
information (e.g., author details, title details) is required as input into text boxes as well as 
upload files. 
You will need to have the following files ready to upload into the system: 
(i) Title Page 
(ii) Main document (including references) 
(iii) Tables – you must input a Table Number and Title for each when uploading 
(iv) Figures/ Image - you must input a Figure Number and Title for each when uploading 
(v) Supplementary on-line only files for publication and review(e.g., original author-designed 
survey instruments) 
(vi) Supplementary files not for publication or review(e.g., reporting guidelines; consent of 
people in photographs etc) 
Figures and Tables 
There is a limit of four tables and/or figures/ images per manuscript. 
Tables 
Tables should be self-contained and complement, but not duplicate, information contained in 
the text. Number tables consecutively in the text in Arabic numerals. Type tables on a 
separate sheet with the legend above. Legends should be concise but comprehensive - the 
table, legend and footnotes must be understandable without reference to the text. Vertical 
lines should not be used to separate columns. Column headings should be brief, with units of 
measurement in parentheses; all abbreviations must be defined in footnotes. Footnote 
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symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-
values. Statistical measures such as SD or SEM should be identified in the headings. 
Table and Figure Titles and Legends 
Legends should be concise but comprehensive - the figure and its legend must be 
understandable without reference to the text. Include definitions of any symbols used and 
define/explain all abbreviations and units of measurement. 
Figures 
All illustrations (line drawings and photographs) are classified as figures. Figures should be 
cited in consecutive order in the text. Magnifications should be indicated using a scale bar on 
the illustration. 
Preparation of Electronic Figures for Publication: Although low quality images are adequate 
for review purposes, publication requires high quality images to prevent the final product 
being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. MS 
PowerPoint and Word Graphics are unsuitable for printed pictures. Do not use pixel-oriented 
programs. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 
dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved 
with fonts embedded (and with a TIFF preview if possible). For scanned images, the 
scanning resolution (at final image size) should be as follows to ensure good reproduction: 
line art: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both 
halftone and line images: >600 dpi. More advice on figures can be found at Wiley’s 
guidelines for preparation of figures: http://authorservices.wiley.com/bauthor/illustration.asp 
Colour figure publication charges. A charge of A$1000/US$530 for the first three colour 
figures and A$500/US$265 for each extra colour figure thereafter will be charged to the 
author. 
Photographs 
Statements of permission to publish must accompany all photographs of identifiable persons 
at the time of submission. Authors must provide signed statements of permission from 
people cited for personal communications at the time of submission. 
6. COPYRIGHT, LICENSING AND ONLINE OPEN 
Accepted papers will be passed to Wiley’s production team for publication. The author 
identified as the formal corresponding author for the paper will receive an email prompting 
them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service 
(WALS) they will be asked to complete an electronic license agreement on behalf of all 
authors on the paper. 
Authors may choose to publish under the terms of the journal’s standard copyright transfer 
agreement (CTA), or under open access terms made available via Wiley OnlineOpen. 
Standard Copyright Transfer Agreement: FAQs about the terms and conditions of the 
standard CTA in place for the journal, including standard terms regarding archiving of the 
accepted version of the paper, are available at: Copyright Terms and Conditions FAQs. 
Note that in signing the journal’s licence agreement authors agree that consent to reproduce 
figures from another source has been obtained. 
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OnlineOpen – Wiley’s Open Access Option: OnlineOpen is available to authors of articles 
who wish to make their article freely available to all on Wiley Online Library under a Creative 
Commons license. With OnlineOpen, the author, the author's funding agency, or the author's 
institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen 
articles are permitted to post the final, published PDF of their article on their personal 
website, and in an institutional repository or other free public server immediately after 
publication. All OnlineOpen articles are treated in the same way as any other article. They go 
through the journal's standard peer-review process and will be accepted or rejected based 
on their own merit. 
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and 
have a choice of publishing under the following Creative Commons License terms: Creative 
Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial 
License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC 
BY NC ND). To preview the terms and conditions of these open access agreements please 
visit the Copyright Terms and Conditions FAQs. 
Funder Open Access and Self-Archiving Compliance: Please click here for more 
information on Wiley’s compliance with specific Funder Open Access and Self Archiving 
Policies, and click here for more detailed information specifically about Self-Archiving 
definitions and policies. 
7. PUBLICATION PROCESS AFTER ACCEPTANCE 
Wiley’s Author Services 
Author Services enables authors to track their article throughout the production process to 
publication online and in print. Authors can check the status of their articles online and 
choose to receive automated e-mails at key stages of production. The corresponding author 
will receive a unique link that enables them to register and have their article automatically 
added to the system. Please ensure that a complete e-mail address is provided when 
submitting the manuscript. Visit www.wileyauthors.com/track for more details on online 
production tracking. 
Proofs 
Once the paper has been typeset the corresponding author will receive an e-mail alert 
containing instructions on how to provide proof corrections to the article. It is therefore 
essential that a working e-mail address is provided for the corresponding author. Proofs 
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